Viewing Study NCT06606184



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06606184
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-16

Brief Title: Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant
Sponsor: None
Organization: None

Study Overview

Official Title: Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients The main questions it aims to answer are

Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery Does the intervention improve pulmonary function and reduce dyspnea sensation

Participants performed

Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise
Detailed Description: Patients undergoing liver transplantation often face significant challenges related to pulmonary rehabilitation Although postoperative rehabilitation has been extensively studied the specific role of pulmonary rehabilitation programs has received limited attention This study aims to evaluate the efficacy of a home-based pulmonary rehabilitation program in improving respiratory function recovery among post-liver transplant patients The training group participated in a 12-week pulmonary rehabilitation program post-discharge emphasizing respiratory muscle and exercise training while the control group received standard care which included traditional rehabilitation

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None